Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

March 2, 2007 Approval Letter - Procleix WNV Assay

March 2, 2007

Our STN: BL 125121/17

Gen-Probe Incorporated
Attn: Leanne M. Kiviharju
10210 Genetic Center Drive
San Diego, CA 92121

Dear Ms. Kiviharju:

We have approved your request to supplement your biologics license application for your Procleix West Nile Virus (WNV) Assay, to allow revised labeling and supporting information for performing the Procleix WNV Assay with the Procleix TIGRIS System.

We will include information contained in the above-referenced supplement in your biologics license application file.

Sincerely yours,


Jay S. Epstein, M.D.
Office of Blood Research and Review

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 07/14/2010
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English